"United Kingdom" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Country in northwestern Europe including Great Britain and the northern one-sixth of Ireland, located between the North Sea and north Atlantic Ocean. The capital is London.
| Descriptor ID |
D006113
|
| MeSH Number(s) |
Z01.542.363
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "United Kingdom".
Below are MeSH descriptors whose meaning is more specific than "United Kingdom".
This graph shows the total number of publications written about "United Kingdom" by people in this website by year, and whether "United Kingdom" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 |
| 1997 | 0 | 4 | 4 |
| 1998 | 0 | 3 | 3 |
| 1999 | 0 | 2 | 2 |
| 2000 | 0 | 3 | 3 |
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 4 | 4 |
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 3 | 3 |
| 2006 | 0 | 3 | 3 |
| 2007 | 0 | 3 | 3 |
| 2008 | 0 | 3 | 3 |
| 2009 | 0 | 4 | 4 |
| 2010 | 0 | 6 | 6 |
| 2011 | 0 | 4 | 4 |
| 2012 | 0 | 3 | 3 |
| 2013 | 0 | 4 | 4 |
| 2014 | 0 | 7 | 7 |
| 2015 | 0 | 6 | 6 |
| 2016 | 0 | 8 | 8 |
| 2017 | 0 | 3 | 3 |
| 2018 | 0 | 9 | 9 |
| 2019 | 0 | 10 | 10 |
| 2020 | 0 | 17 | 17 |
| 2021 | 0 | 19 | 19 |
| 2022 | 0 | 7 | 7 |
| 2023 | 0 | 7 | 7 |
| 2024 | 0 | 7 | 7 |
| 2025 | 0 | 17 | 17 |
| 2026 | 0 | 11 | 11 |
To return to the timeline,
click here.
Below are the most recent publications written about "United Kingdom" by people in Profiles.
-
Stereotactic radiosurgery (SRS) for small cell lung cancer (SCLC) brain metastases: a real-world UK tertiary center experience. Br J Radiol. 2026 Oct 01; 99(1186):2148-2154.
-
Cancer Variant Interpretation Group UK (CanVIG-UK): updates on an exemplar national subspecialty multidisciplinary network. J Med Genet. 2026 Sep 29; 63(10):649-655.
-
Development of a clinical prediction model using volatile organic compounds as breath biomarkers in squamous oesophageal neoplasms: ViSON, protocol for a multicentre case-control study in UK NHS hospitals. BMJ Open. 2026 Sep 28; 16(9):e112493.
-
UK SMA patient registry: a 3-year patient-reported outcome measures study supporting the drug appraisal of Nusinersen and Risdiplam in spinal muscular atrophy. J Neurol Sci. 2026 Nov 15; 490:126159.
-
Oncology drug development in the UK: analysis of the past 25 years and focus on the 2026 reboot of the clinical trial regulatory framework. Br J Cancer. 2026 Oct; 135(8):1286-1297.
-
Pre-operative proton versus photon-based chemoradiotherapy as an addition to best systemic therapy in the management of oesophageal cancer: protocol for the UK multi-centre randomised phase 2 PROTIEUS study. BMC Cancer. 2026 Jun 29; 26(1).
-
Prostate Cancer, Genetic Susceptibility, and Risk of Chronic Non-Urological Complications. Prostate. 2026 06; 86(9):1083-1090.
-
Development of an Integrated Monogenic and Polygenic Risk Assessment Tool for Coronary Artery Disease and Its Application in a Community-Based Health Care Biobank. Circ Genom Precis Med. 2026 Jun; 19(3):e005494.
-
Exome sequencing and analysis of 44,028 British South Asians enriched for high autozygosity. Nat Genet. 2026 Apr; 58(4):821-830.
-
Monogenic and Polygenic Risk for Kidney Cancer in Two Large Biobanks. Eur Urol Oncol. 2026 Jun; 9(3):638-644.